Picture of Neximmune logo

NEXI — Neximmune News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Neximmune Inc expected to post a loss of 51 cents a share - Earnings Preview

* Neximmune Inc  NEXI.OQ   NEXI.O  is expected to report
results on August 9.
​* Refinitiv's mean analyst estimate for Neximmune Inc is for a
loss of 51 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Neximmune Inc
is $35​, about 69.2% above​ its last closing price
of $10.78. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.67       -0.66      -0.71     Missed  -7
                                                        ​
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 6 at 20:32 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Neximmune

See all news